The chapter discusses the results of a study on obesity drugs and their potential benefits beyond weight loss, highlighting their positive effects on reducing the risk of heart attacks and strokes, as well as improving blood sugar levels and inflammation. It explores the effectiveness of newer classes of drugs for weight loss and raises questions about their mechanisms of action and the impact on healthcare costs.
Bloomberg Opinion Pharma Columnist Lisa Jarvis and Bloomberg News Health Reporter Madison Muller discuss a how a clinical trial in obesity drugs is punctuating a string of positive developments that could make the treatments more widely accessible. Kate Hao, Founder and CEO of Happy Mango, talks about helping immigrants secure loans for cars, homes and businesses. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Senior Economics Writer Shawn Donnan provide the details of Shawn's Businessweek story Biden and Xi Meet at APEC to Navigate Rivalry and Economic Ties. And we Drive to the Close with David Dietze, Senior Portfolio Strategist at Peapack Private Wealth Management.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.